Try our Advanced Search for more refined results
Intellectual Property
Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.
Sign up for a 7-day FREE trial today!
Latest News in Intellectual Property
-
March 31, 2026
A Shift In Fed. Circ.'s Approach To Patent Summary Judgment
The Federal Circuit's recent decision in Range of Motion v. Armaid may come to be seen as a seminal opinion for potentially exposing and entrenching the Federal Circuit's movement away from its previous framework for identifying obvious noninfringement cases, says Nicholas Nowak at Nowak IP Group.
-
March 30, 2026
Newsom Tightens AI Contract Rules Over Safety Fears
California Gov. Gavin Newsom on Monday ordered state agencies to strengthen guardrails for all contracts connected to generative AI tools, highlighting what he sees as risks to free speech, voting rights and mass surveillance, and at the same time encouraging statewide adoption of safe forms of the technology.
-
March 30, 2026
Verizon Gets T-Mobile Ads Promising $1K In Savings Blocked
A New York federal judge Monday issued an injunction blocking T-Mobile from running advertisements stating that consumers could save more than $1,000 a year by switching to the carrier, agreeing with Verizon that T-Mobile is pushing a false message and an "apples-to-oranges comparison."
-
March 30, 2026
Cardi B, Atlantic Defeat IP Lawsuit Over Hit Single 'Enough'
A Texas federal judge Monday freed Cardi B from a copyright infringement lawsuit claiming she ripped off two music producers' beats to make her 2024 hit "Enough (Miami)," saying the court lacked personal jurisdiction over the rapper, even if she performed many times in the Lone Star State.
-
March 30, 2026
Don't Set Special IP Rules For 'Skinny Labels,' Justices Told
Drugmakers, industry groups, hospitals and scholars have urged the U.S. Supreme Court to uphold a decision letting a patent suit proceed over a generic drug using a so-called skinny label, saying the generics company is seeking unwarranted special protections that would upend patent law.
Areas of Coverage
- LITIGATION
- Infringement suits over patents, copyrights, and trademarks
- Patent Trial and Appeal Board disputes
- Abbreviated New Drug Application (ANDA) litigation
- Section 301 cases
- Trade secrets disputes
- Licensing and royalty fights
- Right-of-publicity suits
- Antitrust disputes involving IP issues
- AGENCIES
- U.S. Patent and Trademark Office
- U.S. Copyright Office
- U.S. International Trade Commission
- World Intellectual Property Organization
- POLICY & REGULATION
- Patent reform legislation and related bills in Congress
- Efforts to streamline international intellectual property law
- ENFORCEMENT
- Piracy and counterfeiting actions
- International trade disputes involving IP issues
- PROFILES
- Personnel moves
- Profiles of IP practices
Readership
- Intellectual property lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the life sciences, technology, and other IP-focused industries
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals